Terry Chase Hazell

Terry Chase Hazell has advanced innovation and entrepreneurship as a successful start-up executive spinning out companies from Universities, as a university employee advancing innovation, and as a university advisor implementing new programs helping women become entrepreneurs and investors.
Her biotech-specific expertise is recombinant protein production, process scale-up and cGMP manufacturing.
Hazell started her career in biotechnology at Martek Biosciences as a student researcher working with algae and oil production.
Her first leadership position was managing the bioprocess scale-up facility at the University of Maryland where she developed and scaled the production of dozens of biologic products.
She then managed clinical manufacturing projects at one of the most successful independent contract manufacturing organizations, BioScience Contract Production Corporation.
Hazell was the founding CEO of a protein manufacturing and University of Maryland spinout company, Chesapeake PERL.
She led the company from a University idea to a revenue producing and growing company.
In 2003, she led the company through a merger with a competitor.
In Austin, Hazell served as a fractional Vice President of Terapio Corporation where she primarily focused on operations and outsourcing pharmaceutical manufacturing.
Today, she leads RampCorp to increase the number of women running and launching scalable companies and is a member of the National Advisory Board for Springboard Enterprises, helping women access capital.
She leads conferences and boot camps for entrepreneurship an led the entrepreneurship tracks of the Pennsylvania, Massachusetts and Texas Conferences for Women.
She is a Charter Member of the Startup America Partnership's Women's Entrepreneurship Working Group.
She serves on several start-up company boards and advisory boards, is Chair of the Texas Emerging Technology Fund Advisory Committee.